iqvia weight loss prescriptions semaglutide tirzepatide q3 2024 The outlook for obesity from 2026 to 2030 The weight-loss boom has created

[5] [1] Other important safety considerations include risks of pancreatitis, gallbladder disease, acute kidney injury, hypersensitivity reactions, and caution in patients with severe gastrointestinal disease

How common is hyperkalaemia

I started taking it because my doctor wanted to find a better way to manage my blood sugar

What the Clinical Evidence Shows The data supporting GLP-1 medications dual effect on weight and alcohol consumption is growing rapidly across both preclinical and human studies

Several GLP-1 RAs are now licensed for the treatment of type 2 diabetes

This helps prevent skin side effects, like redness or irritation